Additionally, various diseases like cancer—particularly glioblastoma and prostate cancer—as well as metabolic disorders such as type 2 diabetes (T2DM) and insulin resistance are associated with elevated IGFBP-2 levels. The gene discussed is IGFBP2; the disease is prostate carcinoma.